Idera Pharmaceuticals Reports Second Quarter 2022 Financial Results

Provided By Globe Newswire

Last update: Aug 9, 2022

EXTON, Pa., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (“Idera,” the “Company,” “we,” “us,” or “our”) (Nasdaq: IDRA) today reported its financial and operational results for the second quarter ended June 30, 2022.